|
Volumn 13, Issue 8, 2000, Pages 934-939
|
Do patients with de novo hypertension differ from patients with previously known hypertension when Malignant phase hypertension occurs?
|
Author keywords
De novo; Malignant hypertension; Prognosis; Renal function
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CREATININE;
UREA;
ADULT;
AGE;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
BLOOD PRESSURE MEASUREMENT;
CLINICAL FEATURE;
CONTROLLED STUDY;
DATA ANALYSIS;
DATA BASE;
DIASTOLIC BLOOD PRESSURE;
DISEASE SEVERITY;
FEMALE;
FOLLOW UP;
HEALTH CARE QUALITY;
HUMAN;
KIDNEY FUNCTION;
LIFE TABLE;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT HYPERTENSION;
MULTIVARIATE ANALYSIS;
PATIENT CARE;
PRIORITY JOURNAL;
PROGNOSIS;
RACE;
SEX DIFFERENCE;
SURVIVAL;
TREATMENT OUTCOME;
UNITED KINGDOM;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
SURVIVAL ANALYSIS;
|
EID: 0033854447
PISSN: 08957061
EISSN: None
Source Type: Journal
DOI: 10.1016/S0895-7061(99)00283-6 Document Type: Article |
Times cited : (11)
|
References (12)
|